Roles and mechanisms of action of pituitary adenylate cyclase-activating polypeptide (PACAP) in growth hormone and prolactin secretion

Endocrine Journal

Volumn 48, Issue 2, 2001, Pages 123-132

  Murakami, Y ^a   Koshimura, K ^a   Yamauchi, K ^a   Nishiki, M ^a   Tanaka, J ^a   Kato, Y ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; PROLACTIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

GROWTH HORMONE RELEASE; HORMONAL REGULATION; HYPOPHYSIS FUNCTION; NONHUMAN; PARACRINE SIGNALING; PROLACTIN RELEASE; REVIEW; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; ULTRADIAN RHYTHM;

EID: 0034984904     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.48.123     Document Type: Review

References (59)

1. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells
2. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase-activating polypeptide with 38 residues (PACAP38)
3. Tissue distribution of PACAP as determined by RIA: Highly abundant in the rat brain and testis
4. Comparative distribution of immunoreactive pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in rat forebrain
5. Pituitary adenylate cyclase-activating peptide gene expression in corticotropin-releasing factor-containing parvicellular neurons of the rat hypothalamic paraventricular nucleus is induced by colchicine, but not by adrenalectomy, acute osmotic, ether, or restraint stress
6. The expression of pituitary adenylate cyclase-activating polypeptide (PACAP) mRNA in rat brain: Possible role of endogenous PACAP in vasopressin release
7. Pituitary adenylate cyclase-activating polypeptide (PACAP)-like immunoreactive neuronal elements in rat hypothalamus and median eminence with special reference to morphological background of its effect on anterior pituitary-light and electron microscopic immunocytochemistry
8. Localization of pituitary adenylate cyclase-activating polypeptide (PACAP) in the hypothalamus-pituitary system in rats: Light and electron microscopic immunocytochemical studies
9. Colocalization of PACAP, but not VIP, with oxytocin in the hypothalamic magnocellular neurons of colchicine treated and pituitary stalk sectioned rats
10. Cytochemical characterization of anterior pituitary target cells for the neuropeptide, pituitary adenylate cyclase-activating polypeptide (PACAP), using biotinylated ligands
11. Pituitary adenylate cyclase-activating peptide-38 (PACAP-38), PACAP-27, and PACAP related peptide (PRP) in the rat median eminence and pituitary
12. Pituitary adenylate cyclase-activating peptide-38 (PACAP)-38 is released into hypophysial portal blood in the normal male and female rat
13. Differential signal transduction by five splice variants of the PACAP receptor
14. Binding sites for pituitary adenylate cyclase-activating polypeptide (PACAP): Comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain sections
15. Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide receptor in the rat brain: An in situ hybridization study
16. Effects of centrally administered pituitary adenylate cyclase-activating polypeptide on c-fos gene expression and heteronuclear RNA for vasopressin in rat paraventricular and supraoptic nuclei
17. Pituitary adenylate cyclase-activating polypeptide stimulates arginine vasopressin release in conscious rats
18. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on gonadotropin-releasing hormone and somatostatin gene expression in the rat brain
19. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus
20. Differential alternative splicing of PACAP receptor in pituitary cell subpopulations
21. Multiple splice variants of the pituitary adenylate cyclase-activating polypeptide type 1 receptor detected by RT-PCR in single rat pituitary cells
22. Pituitary adenylate cyclase-activating polypeptide regulates prolactin promoter activity via a protein kinase A-mediated pathway that is independent of the transcriptional pathway employed by thyrotropin-releasing hormone
23. Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors
24. Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor
25. Involvement of pituitary adenylate cyclase-activating polypeptide (PACAP) in growth hormone secretion induced by serotoninergic mechanisms in the rat
26. Effect of pituitary adenylate cyclase-activating polypeptide 38 on growth hormone and prolactin expression
27. Contrasting effects of pituitary adenylate cyclase activating polypeptide (PACAP) on in vivo and in vitro prolactin and growth hormone release in male rats
28. Pituitary adenylate cyclase-activating polypeptide specifically increases cytosolic calcium ion concentration in rat gonadotropes and somatotropes
29. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on hormone secretion from sheep pituitary cells in vitro
30. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP), prostaglandin E2 (PGE2) and growth hormone releasing factor (GRF) on the release of growth hormone from cultured bovine anterior pituitary cells in vitro
31. Pituitary adenylate cyclase activating polypeptide (PACAP) stimulates growth hormone release from GH3 cells through type II PACAP receptor
32. Regulation of the pituitary-specific transcription factor GHF-1/Pit-1 messenger ribonucleic acid levels by growth hormone-secretagogues in rat anterior pituitary cells in monolayer culture
33. Pituitary adenylate cyclase-activating polypeptide stimulates prolactin gene expression in a rat pituitary cell line
34. Signalling pathways mediating secretory and mitogenic responses to galanin and pituitary adenylate cyclase-activating polypeptide in the 235-1 clonal rat lactotroph cell line
35. Two types of voltage-dependent calcium currents in rat somatotropes are reduced by somatostatin
36. Imaging of intracellular calcium in rat anterior pituitary cells in response to growth hormone releasing factor
37. Sodium and calcium currents in action potentials of rat somatotrophs: Their possible functions in growth hormone secretion
38. + on GRF-induced GH secretion from rat pituitary cells
39. 3 cells
40. 3 cells and human pituitary adenoma cells by PACAP
41. Pituitary adenylate cyclase-activating polypeptide induces the voltage-independent activation of inward membrane currents and elevation of intracellular calcium in HIT-T15 insulinoma cells
42. 2+-dependent stimulatory effect of pituitary adenylate cyclase-activating polypeptide on catecholamine secretion from cultured porcine adrenal medullary chromaffin cells
43. + current in cultured rat pituitary cells
44. Involvement of tetrodotoxin-sensitive sodium channels in rat growth hormone secretion induced by pituitary adenylate cyclase-activating polypeptide (PACAP)
45. Pituitary adenylate cyclase-activating polypeptide 38 and PACAP27 activate common and distinct intracellular signaling pathways to stimulate growth hormone secretion from porcine somatotropes
46. Pituitary adenylate cyclase-activating polypeptide (PACAP) 38 and PACAP27 differentially stimulate growth hormone release and mRNA accumulation in porcine somatotropes
47. Effects of pituitary adenylate cyclase-activating polypeptide on hormone secretion by human pituitary adenomas in vitro
48. Effect of pituitary adenylate cyclase-activating polypeptide on human somatotrophic tumours in cell culture
49. Receptors for pituitary adenylate cyclase activating peptides in human pituitary adenomas
50. + permeability in perfused cultured rat somatotrophs
51. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on prolactin, luteinizing hormone and growth hormone secretion in the ewe
52. Effects of pituitary adenylate cyclase-activating polypeptide on prolactin, growth hormone and cortisol secretion in normal male subjects
53. Possible involvement of vasoactive intestinal polypeptide in the central stimulating action of pituitary adenylate cyclase-activating polypeptide on prolactin secretion in the rat
54. Passage of pituitary adenylate cyclase activating polypeptidel-27 and pituitary adenylate cyclase activating polypeptidel-38 across the blood-brain barrier
55. Pituitary adenylate cyclase-activating polypeptide (PACAP) increases prolactin and tuberoinfundibular dopaminergic neuronal activity
56. Pituitary adenylate cyclase-activating polypeptide acts within the medial basal hypothalamus to inhibit prolactin and luteinizing hormone secretion
57. PACAP stimulates dopamine neuronal activity in the medial basal hypothalamus and inhibits prolactin
58. Involvement of growth hormone (GH)-releasing factor in GH secretion induced by serotoninergic mechanisms in conscious rats
59. Vasoactive intestinal peptide is a physiological mediator of prolactin release in the rat